December 16, 2015

Helix BioPharma Corp. Announces The Results of Its Annual General Meeting (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, announces that its Annual General Meeting (the “Meeting”) was held today as scheduled.